{
  "ticker": "PTX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02969334",
  "id": "02969334",
  "pages": 5,
  "price_sensitive": true,
  "date": "20250715",
  "time": "0918",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250715/pdf/06lt1lb0n266t7.pdf",
  "summary": "### Summary (Capital Raising Announcement - SPP Extension):  \n\n- **Structure**: Share Purchase Plan (SPP)  \n- **Capital Target**: Up to **$7 million** at **$0.040 per share** (16.7% discount to 15-day VWAP pre-announcement).  \n- **Revised Key Dates**:  \n  - **SPP Close Date**: 22 July 2025 (extended from 15 July).  \n  - **Results Announcement**: 28 July 2025.  \n  - **Share Issue & Trading**: 30\u201331 July 2025.  \n- **Use of Funds**: Advance **PTX-100 Phase 2 clinical development** for regulatory approval.  \n\n*Omitted:* Operational details, background on PTX-100, shareholder briefing info (non-material to trading decision).  \n\n---  \n**Brevity Note**: If only the extension was critical, summary could be further condensed to:  \n- **SPP Closing Date Extended**: To 22 July 2025 (from 15 July). Target: $7M @ $0.040/share.",
  "usage": {
    "prompt_tokens": 2648,
    "completion_tokens": 234,
    "total_tokens": 2882,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-14T23:32:59.557733"
}